Pivot Bio
Biotechnology ResearchCalifornia, United States201-500 Employees
Pivot Bio is one of the world's leading innovative agtech companies, delivering farmers patented crop nutrition technologies.
Expanding Facilities Pivot Bio is actively expanding its research, development, and manufacturing capabilities in Missouri, indicating a strategic focus on scaling innovative crop nutrition solutions and increasing market reach in the United States.
Focus on Sustainability The company's development of microbial-based crop nutrition technology offers a climate-friendly alternative to synthetic nitrogen fertilizers, appealing to environmentally conscious farmers and agribusinesses seeking sustainable practices.
Investment and Growth With a funding magnitude of 600 million dollars and revenue estimates between 100 and 250 million dollars, Pivot Bio demonstrates strong financial backing and momentum, providing opportunities for partner collaborations and new product development.
Technological Innovation Leveraging advanced tech like TensorFlow and data analysis tools, Pivot Bio is at the forefront of agtech innovation, which can be appealing to partners interested in cutting-edge agricultural data insights and precision farming solutions.
Market Positioning Pivot Bio's strategic relocation to Minneapolis and expansion into key agricultural markets highlight its goal to serve cost-sensitive and environmentally regulated segments, offering ample sales opportunities with growers prioritizing efficiency and sustainability.
Pivot Bio uses 8 technology products and services including Linkedin Insight Tag, SQL, Microsoft Intune, and more. Explore Pivot Bio's tech stack below.
| Pivot Bio Email Formats | Percentage |
| FLast@pivotbio.com | 64% |
| First@pivotbio.com | 23% |
| First.Last@pivotbio.com | 10% |
| FirstL@pivotbio.com | 3% |
Biotechnology ResearchCalifornia, United States201-500 Employees
Pivot Bio is one of the world's leading innovative agtech companies, delivering farmers patented crop nutrition technologies.
Pivot Bio has raised a total of $600M of funding over 3 rounds. Their latest funding round was raised on Jul 19, 2021 in the amount of $430Mas a Series D.
Pivot Bio's revenue is estimated to be in the range of $100M$250M
Pivot Bio has raised a total of $600M of funding over 3 rounds. Their latest funding round was raised on Jul 19, 2021 in the amount of $430Mas a Series D.
Pivot Bio's revenue is estimated to be in the range of $100M$250M